急性冠動脈症候群(ACS)の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)

【英語タイトル】Global Acute Coronary Syndrome (ACS) Market by Manufacturers, Countries, Type and Application, Forecast to 2023

GlobalInfoResearchが出版した調査資料(GIR8100030)・商品コード:GIR8100030
・発行会社(調査会社):GlobalInfoResearch
・発行日:2018年10月23日
・ページ数:128
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:世界
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥379,320見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥568,980見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥758,640見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、急性冠動脈症候群(ACS)の世界市場について調べ、まとめました。種類別セグメントは、単剤療法、併用療法等、用途別セグメントは、病院、外来手術センター、診断センター等に区分しました。急性冠動脈症候群(ACS)の世界市場概観、メーカー動向、メーカー別急性冠動脈症候群(ACS)シェア、市場規模推移、市場規模予測、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・急性冠動脈症候群(ACS)の市場概観
・急性冠動脈症候群(ACS)のメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・急性冠動脈症候群(ACS)のメーカー別販売動向、市場シェア、市場集中度、競争動向
・急性冠動脈症候群(ACS)の世界市場規模
・急性冠動脈症候群(ACS)の北米市場分析(アメリカ、カナダ、メキシコ等)
・急性冠動脈症候群(ACS)のアメリカ市場規模推移
・急性冠動脈症候群(ACS)のカナダ市場規模推移
・急性冠動脈症候群(ACS)のメキシコ市場規模推移
・急性冠動脈症候群(ACS)のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・急性冠動脈症候群(ACS)のドイツ市場規模推移
・急性冠動脈症候群(ACS)のイギリス市場規模推移
・急性冠動脈症候群(ACS)のロシア市場規模推移
・急性冠動脈症候群(ACS)のアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・急性冠動脈症候群(ACS)の日本市場規模推移
・急性冠動脈症候群(ACS)の中国市場規模推移
・急性冠動脈症候群(ACS)の韓国市場規模推移
・急性冠動脈症候群(ACS)のインド市場規模推移
・急性冠動脈症候群(ACS)の東南アジア市場規模推移
・急性冠動脈症候群(ACS)の南米市場分析(ブラジル、アルゼンチン等)
・急性冠動脈症候群(ACS)の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・急性冠動脈症候群(ACS)の種類別分析/市場規模推移(単剤療法、併用療法)
・急性冠動脈症候群(ACS)の用途別分析/市場規模推移(病院、外来手術センター、診断センター)
・急性冠動脈症候群(ACS)の市場予測(地域別予測、種類別予測、用途別予測)
・急性冠動脈症候群(ACS)の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Acute coronary syndrome (ACS) is a syndrome (set of signs and symptoms) due to decreased blood flow in the coronary arteries such that part of the heart muscle is unable to function properly or dies. The most common symptom is chest pain, often radiating to the left shoulder or angle of the jaw, crushing, central and associated with nausea and sweating. Many people with acute coronary syndromes present with symptoms other than chest pain, particularly, women, older patients, and patients with diabetes mellitus.

Scope of the Report:

This report studies the Acute Coronary Syndrome (ACS) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Acute Coronary Syndrome (ACS) market by product type and applications/end industries.

Increase in geriatric population and rise in the incidence of cardiac disorders are the major factors that drive the market growth. However, stringent government regulations for the approval of drugs are expected to restrain the market growth. Improvement in healthcare facilities in emerging regions such as Asia-Pacific and LAMEA are expected to provide new growth opportunities for the market during the analysis period.

The global Acute Coronary Syndrome (ACS) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Acute Coronary Syndrome (ACS).

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Dexa Medica

GlaxoSmithKline

Novartis

Pfizer Inc.

Sanofi S.A.

Serum Institute of India

Biogen Inc.

Eli Lilly and Company

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Monotherapy

Combination Therapy

Market Segment by Applications, can be divided into

Hospitals

Ambulatory Surgical Center

Diagnostic Centers

【レポートの目次】

Table of Contents

1 Acute Coronary Syndrome (ACS) Market Overview

1.1 Product Overview and Scope of Acute Coronary Syndrome (ACS)

1.2 Classification of Acute Coronary Syndrome (ACS) by Types

1.2.1 Global Acute Coronary Syndrome (ACS) Revenue Comparison by Types (2017-2023)

1.2.2 Global Acute Coronary Syndrome (ACS) Revenue Market Share by Types in 2017

1.2.3 Monotherapy

1.2.4 Combination Therapy

1.3 Global Acute Coronary Syndrome (ACS) Market by Application

1.3.1 Global Acute Coronary Syndrome (ACS) Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Center

1.3.4 Diagnostic Centers

1.4 Global Acute Coronary Syndrome (ACS) Market by Regions

1.4.1 Global Acute Coronary Syndrome (ACS) Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Acute Coronary Syndrome (ACS) Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Acute Coronary Syndrome (ACS) Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Acute Coronary Syndrome (ACS) Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Acute Coronary Syndrome (ACS) Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Acute Coronary Syndrome (ACS) Status and Prospect (2013-2023)

1.5 Global Market Size of Acute Coronary Syndrome (ACS) (2013-2023)

2 Manufacturers Profiles

2.1 Dexa Medica

2.1.1 Business Overview

2.1.2 Acute Coronary Syndrome (ACS) Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Dexa Medica Acute Coronary Syndrome (ACS) Revenue, Gross Margin and Market Share (2016-2017)

2.2 GlaxoSmithKline

2.2.1 Business Overview

2.2.2 Acute Coronary Syndrome (ACS) Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 GlaxoSmithKline Acute Coronary Syndrome (ACS) Revenue, Gross Margin and Market Share (2016-2017)

2.3 Novartis

2.3.1 Business Overview

2.3.2 Acute Coronary Syndrome (ACS) Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Novartis Acute Coronary Syndrome (ACS) Revenue, Gross Margin and Market Share (2016-2017)

2.4 Pfizer Inc.

2.4.1 Business Overview

2.4.2 Acute Coronary Syndrome (ACS) Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Pfizer Inc. Acute Coronary Syndrome (ACS) Revenue, Gross Margin and Market Share (2016-2017)

2.5 Sanofi S.A.

2.5.1 Business Overview

2.5.2 Acute Coronary Syndrome (ACS) Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Sanofi S.A. Acute Coronary Syndrome (ACS) Revenue, Gross Margin and Market Share (2016-2017)

2.6 Serum Institute of India

2.6.1 Business Overview

2.6.2 Acute Coronary Syndrome (ACS) Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Serum Institute of India Acute Coronary Syndrome (ACS) Revenue, Gross Margin and Market Share (2016-2017)

2.7 Biogen Inc.

2.7.1 Business Overview

2.7.2 Acute Coronary Syndrome (ACS) Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Biogen Inc. Acute Coronary Syndrome (ACS) Revenue, Gross Margin and Market Share (2016-2017)

2.8 Eli Lilly and Company

2.8.1 Business Overview

2.8.2 Acute Coronary Syndrome (ACS) Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Eli Lilly and Company Acute Coronary Syndrome (ACS) Revenue, Gross Margin and Market Share (2016-2017)

3 Global Acute Coronary Syndrome (ACS) Market Competition, by Players

3.1 Global Acute Coronary Syndrome (ACS) Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Acute Coronary Syndrome (ACS) Players Market Share

3.2.2 Top 10 Acute Coronary Syndrome (ACS) Players Market Share

3.3 Market Competition Trend

4 Global Acute Coronary Syndrome (ACS) Market Size by Regions

4.1 Global Acute Coronary Syndrome (ACS) Revenue and Market Share by Regions

4.2 North America Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

4.3 Europe Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

4.5 South America Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

5 North America Acute Coronary Syndrome (ACS) Revenue by Countries

5.1 North America Acute Coronary Syndrome (ACS) Revenue by Countries (2013-2018)

5.2 USA Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

5.3 Canada Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

5.4 Mexico Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

6 Europe Acute Coronary Syndrome (ACS) Revenue by Countries

6.1 Europe Acute Coronary Syndrome (ACS) Revenue by Countries (2013-2018)

6.2 Germany Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

6.3 UK Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

6.4 France Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

6.5 Russia Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

6.6 Italy Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Acute Coronary Syndrome (ACS) Revenue by Countries

7.1 Asia-Pacific Acute Coronary Syndrome (ACS) Revenue by Countries (2013-2018)

7.2 China Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

7.3 Japan Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

7.4 Korea Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

7.5 India Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

8 South America Acute Coronary Syndrome (ACS) Revenue by Countries

8.1 South America Acute Coronary Syndrome (ACS) Revenue by Countries (2013-2018)

8.2 Brazil Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

8.3 Argentina Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

8.4 Colombia Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Acute Coronary Syndrome (ACS) by Countries

9.1 Middle East and Africa Acute Coronary Syndrome (ACS) Revenue by Countries (2013-2018)

9.2 Saudi Arabia Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

9.3 UAE Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

9.4 Egypt Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

9.5 Nigeria Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

9.6 South Africa Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

10 Global Acute Coronary Syndrome (ACS) Market Segment by Type

10.1 Global Acute Coronary Syndrome (ACS) Revenue and Market Share by Type (2013-2018)

10.2 Global Acute Coronary Syndrome (ACS) Market Forecast by Type (2018-2023)

10.3 Monotherapy Revenue Growth Rate (2013-2023)

10.4 Combination Therapy Revenue Growth Rate (2013-2023)

11 Global Acute Coronary Syndrome (ACS) Market Segment by Application

11.1 Global Acute Coronary Syndrome (ACS) Revenue Market Share by Application (2013-2018)

11.2 Acute Coronary Syndrome (ACS) Market Forecast by Application (2018-2023)

11.3 Hospitals Revenue Growth (2013-2018)

11.4 Ambulatory Surgical Center Revenue Growth (2013-2018)

11.5 Diagnostic Centers Revenue Growth (2013-2018)

12 Global Acute Coronary Syndrome (ACS) Market Size Forecast (2018-2023)

12.1 Global Acute Coronary Syndrome (ACS) Market Size Forecast (2018-2023)

12.2 Global Acute Coronary Syndrome (ACS) Market Forecast by Regions (2018-2023)

12.3 North America Acute Coronary Syndrome (ACS) Revenue Market Forecast (2018-2023)

12.4 Europe Acute Coronary Syndrome (ACS) Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Acute Coronary Syndrome (ACS) Revenue Market Forecast (2018-2023)

12.6 South America Acute Coronary Syndrome (ACS) Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Acute Coronary Syndrome (ACS) Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures



Figure Acute Coronary Syndrome (ACS) Picture

Table Product Specifications of Acute Coronary Syndrome (ACS)

Table Global Acute Coronary Syndrome (ACS) and Revenue (Million USD) Market Split by Product Type

Figure Global Acute Coronary Syndrome (ACS) Revenue Market Share by Types in 2017

Figure Monotherapy Picture

Figure Combination Therapy Picture

Table Global Acute Coronary Syndrome (ACS) Revenue (Million USD) by Application (2013-2023)

Figure Acute Coronary Syndrome (ACS) Revenue Market Share by Applications in 2017

Figure Hospitals Picture

Figure Ambulatory Surgical Center Picture

Figure Diagnostic Centers Picture

Table Global Market Acute Coronary Syndrome (ACS) Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Acute Coronary Syndrome (ACS) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Acute Coronary Syndrome (ACS) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Acute Coronary Syndrome (ACS) Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Acute Coronary Syndrome (ACS) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Acute Coronary Syndrome (ACS) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Acute Coronary Syndrome (ACS) Revenue (Million USD) and Growth Rate (2013-2023)

Table Dexa Medica Basic Information, Manufacturing Base and Competitors

Table Dexa Medica Acute Coronary Syndrome (ACS) Type and Applications

Table Dexa Medica Acute Coronary Syndrome (ACS) Revenue, Gross Margin and Market Share (2016-2017)

Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors

Table GlaxoSmithKline Acute Coronary Syndrome (ACS) Type and Applications

Table GlaxoSmithKline Acute Coronary Syndrome (ACS) Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Acute Coronary Syndrome (ACS) Type and Applications

Table Novartis Acute Coronary Syndrome (ACS) Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Inc. Basic Information, Manufacturing Base and Competitors

Table Pfizer Inc. Acute Coronary Syndrome (ACS) Type and Applications

Table Pfizer Inc. Acute Coronary Syndrome (ACS) Revenue, Gross Margin and Market Share (2016-2017)

Table Sanofi S.A. Basic Information, Manufacturing Base and Competitors

Table Sanofi S.A. Acute Coronary Syndrome (ACS) Type and Applications

Table Sanofi S.A. Acute Coronary Syndrome (ACS) Revenue, Gross Margin and Market Share (2016-2017)

Table Serum Institute of India Basic Information, Manufacturing Base and Competitors

Table Serum Institute of India Acute Coronary Syndrome (ACS) Type and Applications

Table Serum Institute of India Acute Coronary Syndrome (ACS) Revenue, Gross Margin and Market Share (2016-2017)

Table Biogen Inc. Basic Information, Manufacturing Base and Competitors

Table Biogen Inc. Acute Coronary Syndrome (ACS) Type and Applications

Table Biogen Inc. Acute Coronary Syndrome (ACS) Revenue, Gross Margin and Market Share (2016-2017)

Table Eli Lilly and Company Basic Information, Manufacturing Base and Competitors

Table Eli Lilly and Company Acute Coronary Syndrome (ACS) Type and Applications

Table Eli Lilly and Company Acute Coronary Syndrome (ACS) Revenue, Gross Margin and Market Share (2016-2017)

Table Global Acute Coronary Syndrome (ACS) Revenue (Million USD) by Players (2013-2018)

Table Global Acute Coronary Syndrome (ACS) Revenue Share by Players (2013-2018)

Figure Global Acute Coronary Syndrome (ACS) Revenue Share by Players in 2016

Figure Global Acute Coronary Syndrome (ACS) Revenue Share by Players in 2017

Figure Global Top 5 Players Acute Coronary Syndrome (ACS) Revenue Market Share in 2017

Figure Global Top 10 Players Acute Coronary Syndrome (ACS) Revenue Market Share in 2017

Figure Global Acute Coronary Syndrome (ACS) Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Acute Coronary Syndrome (ACS) Revenue (Million USD) by Regions (2013-2018)

Table Global Acute Coronary Syndrome (ACS) Revenue Market Share by Regions (2013-2018)

Figure Global Acute Coronary Syndrome (ACS) Revenue Market Share by Regions (2013-2018)

Figure Global Acute Coronary Syndrome (ACS) Revenue Market Share by Regions in 2017

Figure North America Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

Figure Europe Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

Figure South America Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

Table North America Acute Coronary Syndrome (ACS) Revenue by Countries (2013-2018)

Table North America Acute Coronary Syndrome (ACS) Revenue Market Share by Countries (2013-2018)

Figure North America Acute Coronary Syndrome (ACS) Revenue Market Share by Countries (2013-2018)

Figure North America Acute Coronary Syndrome (ACS) Revenue Market Share by Countries in 2017

Figure USA Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

Figure Canada Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

Figure Mexico Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

Table Europe Acute Coronary Syndrome (ACS) Revenue (Million USD) by Countries (2013-2018)

Figure Europe Acute Coronary Syndrome (ACS) Revenue Market Share by Countries (2013-2018)

Figure Europe Acute Coronary Syndrome (ACS) Revenue Market Share by Countries in 2017

Figure Germany Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

Figure UK Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

Figure France Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

Figure Russia Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

Figure Italy Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Acute Coronary Syndrome (ACS) Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Acute Coronary Syndrome (ACS) Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Acute Coronary Syndrome (ACS) Revenue Market Share by Countries in 2017

Figure China Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

Figure Japan Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

Figure Korea Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

Figure India Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

Table South America Acute Coronary Syndrome (ACS) Revenue by Countries (2013-2018)

Table South America Acute Coronary Syndrome (ACS) Revenue Market Share by Countries (2013-2018)

Figure South America Acute Coronary Syndrome (ACS) Revenue Market Share by Countries (2013-2018)

Figure South America Acute Coronary Syndrome (ACS) Revenue Market Share by Countries in 2017

Figure Brazil Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

Figure Argentina Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

Figure Colombia Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Acute Coronary Syndrome (ACS) Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Acute Coronary Syndrome (ACS) Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Acute Coronary Syndrome (ACS) Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Acute Coronary Syndrome (ACS) Revenue Market Share by Countries in 2017

Figure Saudi Arabia Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

Figure UAE Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

Figure Egypt Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

Figure Nigeria Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

Figure South Africa Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

Table Global Acute Coronary Syndrome (ACS) Revenue (Million USD) by Type (2013-2018)

Table Global Acute Coronary Syndrome (ACS) Revenue Share by Type (2013-2018)

Figure Global Acute Coronary Syndrome (ACS) Revenue Share by Type (2013-2018)

Figure Global Acute Coronary Syndrome (ACS) Revenue Share by Type in 2017

Table Global Acute Coronary Syndrome (ACS) Revenue Forecast by Type (2018-2023)

Figure Global Acute Coronary Syndrome (ACS) Market Share Forecast by Type (2018-2023)

Figure Global Monotherapy Revenue Growth Rate (2013-2018)

Figure Global Combination Therapy Revenue Growth Rate (2013-2018)

Table Global Acute Coronary Syndrome (ACS) Revenue by Application (2013-2018)

Table Global Acute Coronary Syndrome (ACS) Revenue Share by Application (2013-2018)

Figure Global Acute Coronary Syndrome (ACS) Revenue Share by Application (2013-2018)

Figure Global Acute Coronary Syndrome (ACS) Revenue Share by Application in 2017

Table Global Acute Coronary Syndrome (ACS) Revenue Forecast by Application (2018-2023)

Figure Global Acute Coronary Syndrome (ACS) Market Share Forecast by Application (2018-2023)

Figure Global Hospitals Revenue Growth Rate (2013-2018)

Figure Global Ambulatory Surgical Center Revenue Growth Rate (2013-2018)

Figure Global Diagnostic Centers Revenue Growth Rate (2013-2018)

Figure Global Acute Coronary Syndrome (ACS) Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Acute Coronary Syndrome (ACS) Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Acute Coronary Syndrome (ACS) Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Acute Coronary Syndrome (ACS) Revenue Market Forecast (2018-2023)

Figure Europe Acute Coronary Syndrome (ACS) Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Acute Coronary Syndrome (ACS) Revenue Market Forecast (2018-2023)

Figure South America Acute Coronary Syndrome (ACS) Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Acute Coronary Syndrome (ACS) Revenue Market Forecast (2018-2023)



【掲載企業】

Dexa Medica、GlaxoSmithKline、Novartis、Pfizer Inc.、Sanofi S.A.、Serum Institute of India、Biogen Inc.、Eli Lilly and Company

【レポートのキーワード】

急性冠動脈症候群(ACS)、単剤療法、併用療法、病院、外来手術センター、診断センター

★調査レポート[急性冠動脈症候群(ACS)の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)] (コード:GIR8100030)販売に関する免責事項を必ずご確認ください。
★調査レポート[急性冠動脈症候群(ACS)の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆